William John Gradishar MD, FACPBetsy Bramsen Professor of Breast Oncology, Division of Hematology and Medical Oncology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois
Dr. William J. Gradishar is Betsy Bramsen Professor of Breast Oncology in the Division of Hematology and Medical Oncology, Department of Medicine, at the Feinberg School Medicine at Northwestern University in Chicago, Illinois, and a member of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. He serves as Director of the Maggie Daley Center for Women’s Cancer Care. He has been Chair of the Annual Lynn Sage Breast Cancer Symposium since its inception. His research focuses on the development of novel therapeutics for the treatment of breast cancer.
A Fellow of the American College of Physicians, Dr. Gradishar is also a member of the American Association for Cancer Research, the American Federation for Clinical Research, and the Association of Subspecialty Professors. He is past chair of the Oncology Training Program Committee and Communications Committee of the American Society of Clinical Oncology (ASCO). He is Chair-elect of the ASCO Professional Development Committee as well as a member of ASCO’s Scientific Program Committee. He is a member of the Breast Cancer Core Committee and Co-Chair of the Developmental Therapeutics Working Group of the Eastern Cooperative Oncology Group, the Committee on Cancer of the American College of Surgeons, the National Comprehensive Cancer Network (NCCN) Breast Cancer Guidelines Panel, and the NCCN Breast Cancer Prevention Panel. In addition, he serves as a consultant to the Oncology Drug Advisory Committee of the FDA. He has served on numerous study sections including: NIH, NCI, ACS, Komen, and Alberta Cancer Board. He is a member of the editorial board for numerous journals, including Journal of Clinical Oncology, Oncology, Clinical Breast Cancer, Journal Watch, European Journal of Clinical and Medical Oncology and Clinical Cancer Research. He has published in the area of breast cancer therapeutics, with a focus on new endocrine therapy, chemotherapy and biologic agents. Dr. Gradishar was recently awarded the Betsy Bramsen Endowed Chair of Breast Oncology at Northwestern University.
Dr. Gradishar received his medical degree form the University of Illinois Abraham School Of Medicine in Chicago. He completed a residency and chief residency in internal medicine at Michael Reese Hospital and Medical Center in Chicago and a clinical research fellowship in medical oncology at the University of Chicago.
Recent Contributions to PracticeUpdate:
- Alpelisib and T-DM1 for HER2-Positive Metastatic Breast Cancer
- Baseline Circulating ESR1 Mutation Analysis From the EFECT Study
- Updates on Contemporary Management of ER+ Metastatic Breast Cancer
- Clinical Utility of Circulating Tumor Cells and Cell-Free Tumor DNA in Breast Cancer
- Systemic Therapy for Local Recurrence of Breast Cancer: An Overview From SABCS 2017
- Adding Anthracyclines for HER2+ Disease
- Liquid Biopsies' and Endocrine Therapy: An Update From SABCS 2016
- Current Advances and Research in Breast Cancer: An Overview
- Mechanisms and Implications of HER2 Resistance: An Interview With Dr. William Gradishar
- An Overview of Immunotherapy in Breast Cancer